ICPAD 2018 – Videos

 Day 1 - Wednesday 8 November

 
 Session 1: Pharmacological challenges of immunotherapeutics 
 Biomarker in immuno-oncology, are we close?
(Not yet available)
Josep María Piulats, MD, PhD
Catalan Institute of Oncology, Spain
 
   
 Session 2: Dose individualization approaches 
 

Cytotoxic agents
Markus Jörger, MD, PhD
Cantonal Hospital, Switzerland

from Virology Education on Vimeo.

 
 

Targeted agents and monoclonal antibodies
Joseph Ciccolini, PharmD, PhD
Aix-Marseille Université, France

 

from Virology Education on Vimeo.

 
 Using pharmacogenetics to improve drug therapy:
a 12 year experience with clinical implementation
(Not yet available)
Ron van Schaik, PhD, FACB
Erasmus Medical Centre, the Netherlands
 
   

 Day 2 - Wednesday 9 November

 
 Session 3: Combination therapy – old school is becoming new school again 
 

Immunotherapy of prostate cancer and urothelial cancer. Future directions
Winald Gerritsen, MD, PhD
Radboud University, the Netherlands

 

from Virology Education on Vimeo.

 
 

Rationale for selecting combinations with immunotherapy
Howard Gurney, MBBS, FRACP
Westmead Hospital, Australia

 

from Virology Education on Vimeo.

 
   
 Session 4: Drug-Drug / Drug-Food / Drug-environmental interactions 
 

Drug-Drug interactions with targeted oncolytics (in particular PPIs and TKIs)
Ron Mathijssen, MD, PhD
Erasmus Medical Centre, the Netherlands

 

from Virology Education on Vimeo.

 
 

Pharmacotherapy of Comorbities: Cancer Patients with HIV/AIDS
Michelle Rudek, PharmD, PhD
Johns Hopkins University School of Medicine, USA

 

from Virology Education on Vimeo.

 
 

Drug-drug interaction management with DDI-Predictor
Michel Tod, PharmD, PhD
Faculté de Médecine Lyon-Sud, University of Lyon, France

 

from Virology Education on Vimeo.

 
   
 Session 5: Approaches to shorten phase II studies by the use of different read out endpoints 
 

The value of surrogate endpoints in the benefit-risk assessment of new drugs
Gabe Sonke, MD, PhD
Netherlands Cancer Institute, the Netherlands

 

from Virology Education on Vimeo.

 
 

Clinical relevance of liquid biopsy in cancer patients
Catherine Alix-Panabières, PhD
University Medical Centre of Montpellier, France

 

from Virology Education on Vimeo.

 
   
 Session 6: PK/PD studies and new strategies 
 

How studies can be optimized by simultaneous use of PK/PD outcome measurement?
Alwin Huitema, PharmD, PhD
Netherlands Cancer Institute, the Netherlands

 

from Virology Education on Vimeo.